|
1
|
Chemotherapy and survival benefit in elderly patients with advanced non-small-cell lung cancer.
|
J Clin Oncol
|
2010
|
2.25
|
|
2
|
Burden associated with chronic sleep maintenance insomnia characterized by nighttime awakenings among women with menopausal symptoms.
|
Menopause
|
2010
|
1.52
|
|
3
|
Health disparities in staging of SEER-medicare prostate cancer patients in the United States.
|
Urology
|
2010
|
1.50
|
|
4
|
Effect of urologists and medical oncologists on treatment of elderly men with Stage IV prostate cancer.
|
Urology
|
2011
|
1.44
|
|
5
|
Good research practices for measuring drug costs in cost effectiveness analyses: issues and recommendations: the ISPOR Drug Cost Task Force report--Part I.
|
Value Health
|
2009
|
1.22
|
|
6
|
The cost of poor sleep: workplace productivity loss and associated costs.
|
J Occup Environ Med
|
2010
|
1.20
|
|
7
|
Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer.
|
J Am Geriatr Soc
|
2009
|
1.11
|
|
8
|
Population-based estimates of survival benefit associated with combined modality therapy in elderly patients with locally advanced non-small cell lung cancer.
|
J Thorac Oncol
|
2011
|
0.99
|
|
9
|
Good research practices for measuring drug costs in cost-effectiveness analyses: Medicare, Medicaid and other US government payers perspectives: the ISPOR Drug Cost Task Force report--Part IV.
|
Value Health
|
2009
|
0.98
|
|
10
|
Adherence to inhaled corticosteroid use and local adverse events in persistent asthma.
|
Am J Manag Care
|
2008
|
0.97
|
|
11
|
Algorithm for identifying chemotherapy/biological regimens for metastatic colon cancer in SEER-Medicare.
|
Med Care
|
2015
|
0.93
|
|
12
|
Chemotherapy treatment and survival in older women with estrogen receptor-negative metastatic breast cancer: a population-based analysis.
|
J Am Geriatr Soc
|
2011
|
0.91
|
|
13
|
Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancer.
|
BMC Med Res Methodol
|
2014
|
0.86
|
|
14
|
Insomnia-related comorbidities and economic costs among a commercially insured population in the United States.
|
Curr Med Res Opin
|
2009
|
0.85
|
|
15
|
Asthma costs and utilization in a managed care organization.
|
J Allergy Clin Immunol
|
2008
|
0.83
|
|
16
|
Economic implications of rasburicase treatment in adult patients with tumour lysis syndrome.
|
Appl Health Econ Health Policy
|
2012
|
0.82
|
|
17
|
Impact of metastatic colorectal cancer stage and number of treatment courses on patient health care costs and utilization.
|
Postgrad Med
|
2013
|
0.80
|
|
18
|
Economic comparison of rasburicase and allopurinol for treatment of tumor lysis syndrome in pediatric patients.
|
Am J Health Syst Pharm
|
2010
|
0.80
|
|
19
|
Comparative and cost effectiveness of treatment modalities for hepatocellular carcinoma in SEER-Medicare.
|
Pharmacoeconomics
|
2014
|
0.80
|
|
20
|
Treatment costs associated with community-acquired pneumonia by community level of antimicrobial resistance.
|
J Antimicrob Chemother
|
2008
|
0.79
|
|
21
|
Does the type of first-line regimens influence the receipt of second-line chemotherapy treatment? An analysis of 3211 metastatic colon cancer patients.
|
Cancer Med
|
2014
|
0.78
|
|
22
|
A comparison of mortality and costs associated with FOLFOX versus FOLFIRI in stage IV colorectal cancer.
|
J Med Econ
|
2011
|
0.78
|
|
23
|
Multispecialist Care and Mortality in Hepatocellular Carcinoma.
|
Am J Clin Oncol
|
2015
|
0.78
|
|
24
|
Assessing the relationship between compliance with antidepressant therapy and employer costs among employees in the United States.
|
J Occup Environ Med
|
2010
|
0.77
|
|
25
|
Transarterial chemoembolization treatment: association between multiple treatments, cumulative expenditures, and survival.
|
Value Health
|
2013
|
0.77
|
|
26
|
Adverse events and intravenous versus oral bisphosphonate use in patients with osteoporosis and cancer in the U.S.
|
Gen Dent
|
2010
|
0.76
|
|
27
|
Cost-effectiveness of second-line chemotherapy/biologics among elderly metastatic colon cancer patients.
|
Adv Ther
|
2014
|
0.75
|
|
28
|
Pharmacoeconomics of levocetirizine in allergic rhinitis and chronic idiopathic urticaria: considerations for the USA.
|
Expert Rev Pharmacoecon Outcomes Res
|
2008
|
0.75
|
|
29
|
Economic evaluations in pain management: principles and methods.
|
J Pain Palliat Care Pharmacother
|
2006
|
0.75
|